南京威尔药业集团股份有限公司 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603351 证券简称：威尔药业 公告编号：2026-001 本次减持计划不包含公司控股股东及实际控制人吴仁荣先生、高正松先生、陈新国先生在舜泰宗华间接 持有的份额，公司控股股东及实际控制人不以任何方式减持其在舜泰宗华间接持有的公司股份。 一、减持主体的基本情况 ■ 关于股东集中竞价减持股份计划公告 上述减持主体存在一致行动人： 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 大股东持股的基本情况 南京舜泰宗华创业投资合伙企业（有限合伙）（以下简称"舜泰宗华"）为南京威尔药业集团股份有限公 司（以下简称"公司"）的员工持股平台。截至本公告披露日，舜泰宗华持有公司股份8,788,699股，约占 公司总股本的6.49%。股份来源为首次公开发行前持有及上市后资本公积转增股本取得。 ● 减持计划的主要内容 舜泰宗华拟自2026年3月23日至4月10日期间通过集中竞价交易方式，合计减持公司股份不超过446,340 股， ...

证券代码：603351 证券简称：威尔药业 公告编号：2026-001 南京威尔药业集团股份有限公司 关于股东集中竞价减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 大股东持股的基本情况 | 股东名称 | 南京舜泰宗华创业投资合伙企业（有限合伙） | | | | | | --- | --- | --- | --- | --- | --- | | 计划减持数量 | 不超过：446,340 股 | | | | | | 计划减持比例 | 不超过：0.33% | | | | | | 减持方式及对应减持数量 | 集中竞价减持，不超过：446,340 股 | | | | | | 减持期间 | 年 月 日 2026 3 23 4 | 日～2026 | 年 | 月 | 10 | | 拟减持股份来源 | 首次公开发行前持有及上市后资本公积转增股本取得 | | | | | | 拟减持原因 | 股东资金需求 | | | | | 南京舜泰宗华创业投资合伙企业（有限合伙）（以下简称"舜泰宗华"）为南 京威尔药 ...

据统计，2月26日，盘后天壕能源披露增持情况。包括梦洁股份、宏盛华源、方正科技、通光线缆、趣 睡科技、昊志机电、新亚强、银河电子、威尔药业、生益科技在内的10家A股上市公司披露减持情况。 | | | 2.26上市公司盘后增持情况 | | --- | --- | --- | | 1 | 天壕能源 | 取得全融机构股票回购专项贷款承诺函 | | | | 2.26上市公司盘后增持情况 | | 1 | 梦洁股份 | 股东李建伟拟减持不超0.43%股份 | | 2 | 宏盛华源 | 股东国新建源及建信投资拟合计减持不超1%股份 | | 3 | 方正科技 | 股东方正信息产业拟减持不超3.00%股份 | | ব | 通光线缆 | 控股股东通光集团及董事长张忠拟合计减持不超3.021%股份 | | 5 | 吴志机电 | 苗事雷群拟减持不超0.11%股份 | | 6 | 脚睡科技 | 股东李亮拟减持不超1.40%股份 | | 1 | 新闻 | 股东红塔创新、孙秀杰拟合计减持不超4%股份 | | 8 | 银河电子 | 控股股东银河电子集团投资有限公司拟减持不超0.81%股份 | | g | 威尔药业 | 股东舜泰宗华拟减持不超 ...

Core Viewpoint - On February 26, Tianhao Energy disclosed its stock repurchase commitment, while ten A-share listed companies announced their plans for share reduction, indicating a mixed sentiment in the market [1][3]. Group 1: Stock Buyback and Reduction Announcements - Tianhao Energy has obtained a commitment letter for a stock repurchase from a full融 institution [2]. - The following companies announced share reductions: - Mengjie Co., Ltd.: Shareholder Li Jianwei plans to reduce holdings by no more than 0.43% [5]. - Hongsheng Huayuan: Shareholders Guo Xin Jian Yuan and Jianxin Investment plan to collectively reduce holdings by no more than 1% [5]. - Founder Technology: Shareholder Founder Information Industry plans to reduce holdings by no more than 3% [5]. - Tongguang Cable: Controlling shareholder Tongguang Group and Chairman Zhang Zhong plan to reduce holdings by no more than 3.021% [5]. - Wu Zhi Machinery: Director Lei Qun plans to reduce holdings by no more than 0.11% [5]. - Qusleep Technology: Shareholder Li Liang plans to reduce holdings by no more than 1.4% [5]. - Xinyaqiang: Shareholders Hongta Innovation and Sun Xiujie plan to collectively reduce holdings by no more than 4% [5]. - Galaxy Electronics: Controlling shareholder Galaxy Electronics Group Investment Co., Ltd. plans to reduce holdings by no more than 0.81% [5]. - Weier Pharmaceutical: Shareholder Shuntai Zonghua plans to reduce holdings by no more than 0.33% [5]. - Shengyi Technology: Guangxin Group and Chen Renxi have completed their reduction plan [5]. Group 2: Market Signals - The formation of a MACD golden cross signal indicates a positive trend for certain stocks, suggesting potential upward movement in the market [3].

格隆汇2月26日丨威尔药业(603351.SH)公布，舜泰宗华拟自2026年3月23日至4月10日期间通过集中竞价 交易方式，合计减持公司股份不超过44.63万股，即不超过公司总股本的0.33%。 ...

Core Viewpoint - The recent financial report of Weir Pharmaceutical (603351) indicates modest growth in revenue and net profit for the first three quarters of 2025, reflecting the company's stable performance amidst market conditions [1] Financial Performance - The company achieved a revenue of 1.018 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 1.79% [1] - The net profit attributable to shareholders reached 114 million yuan, showing a year-on-year growth of 1.03% [1] Corporate Activities - Weir Pharmaceutical held a shareholders' meeting on December 16, 2025, to review relevant proposals [1] - The schedule for the 2026 annual shareholders' meeting has not yet been announced [1] - No specific major events for 2026 have been disclosed in recent public information, indicating a need for investors to monitor upcoming regular reports and official announcements [1]

Group 1 - The Shanghai Composite Index is at 4108.66 points, slightly down by 0.42%, with a total trading volume of 23623.15 billion yuan [1] - A total of 43 A-shares have surpassed their annual line today, with notable stocks showing significant deviation rates including Guangming Real Estate at 8.90%, Shenyu Co. at 6.99%, and Keheng Co. at 6.61% [1] - The stocks that have just crossed the annual line with smaller deviation rates include Ruipu Biotech, Yingtai Biotech, and Shanghai Phoenix [1] Group 2 - The top three stocks with the highest deviation rates from the annual line are: - Guangming Real Estate: 10.09% increase, trading at 3.82 yuan, with a deviation rate of 8.90% [1] - Shenyu Co.: 11.58% increase, trading at 43.08 yuan, with a deviation rate of 6.99% [1] - Keheng Co.: 11.72% increase, trading at 14.11 yuan, with a deviation rate of 6.61% [1] - Other notable stocks with significant increases include: - Shanghai Ailuo: 5.92% increase, trading at 9.31 yuan, with a deviation rate of 5.53% [1] - Lingpai Technology: 11.44% increase, trading at 31.47 yuan, with a deviation rate of 3.93% [1]

Core Viewpoint - The A-share market shows a mixed performance with a slight increase in the Shanghai Composite Index, while several stocks are experiencing a death cross between their 5-day and 10-day moving averages, indicating potential bearish trends [1] Group 1: Market Overview - As of 10:30 AM, the Shanghai Composite Index is at 3921.77 points, with a change of 0.49% [1] - The total trading volume of A-shares today is 981.369 billion yuan [1] Group 2: Stocks with Death Cross - A total of 315 A-shares have seen their 5-day moving averages cross below their 10-day moving averages [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - China Merchants Energy (招商轮船) with a distance of -2.04% [1] - Chlor-alkali Chemical (氯碱化工) at -1.69% [1] - Tianci Materials (天赐材料) at -1.47% [1] Group 3: Individual Stock Performance - China Merchants Energy (601872) is down 1.20% with a latest price of 8.22 yuan, which is 6.01% below its 10-day moving average [1] - Chlor-alkali Chemical (600618) has decreased by 2.61%, with a latest price of 12.29 yuan, 4.09% below its 10-day moving average [1] - Tianci Materials (002709) increased by 1.74%, with a latest price of 39.26 yuan, 2.37% below its 10-day moving average [1]

证券代码：603351 证券简称：威尔药业 公告编号：2025-037 南京威尔药业集团股份有限公司 关于完成工商备案登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 南京威尔药业集团股份有限公司董事会 2025 年 12 月 5日 特此公告。 南京威尔药业集团股份有限公司（以下简称"公司"）于 2025 年 10 月 29 日召 开第三届董事会第十三次会议及 2025 年 11 月 14 日召开 2025 年第一次临时股东大会， 审议通过《关于取消监事会并修订<公司章程>的议案》。具体内容详见公司在上海证 券交易所网站（www.sse.com.cn）披露的《关于取消监事会并修订<公司章程>的公告》 （公告编号：2025-033）及《公司章程（2025年10月）》。 公司近日已在南京市市场监督管理局完成上述事项备案登记并取得《登记通知 书》。根据企业登记规范要求，对《公司章程》第十一章 附则 第二百〇二条 释义 新 增如下：（四）本章程所称"总裁"即《公司法》中的 "总经理"，"副总裁"即 《公司法》中的 "副总经理 ...

南京威尔药业集团股份有限公司 章 程 二〇二五年十一月 1/50 | 第一章 | 总则 4 | | | --- | --- | --- | | 第二章 | 经营宗旨和范围 5 | | | 第三章 | 股份 | 6 | | 第一节 | 股份发行 | 6 | | 第二节 | 股份增减和回购 8 | | | 第三节 | 股份转让 | 9 | | 第四章 | 股东和股东会 | 10 | | 第一节 | 股东的一般规定 10 | | | 第二节 | 控股股东和实际控制人 14 | | | 第三节 | 股东会的一般规定 15 | | | 第四节 | 股东会的召集 17 | | | 第五节 | 股东会的提案与通知 19 | | | 第六节 | 股东会的召开 21 | | | 第七节 | 股东会的表决和决议 24 | | | 第五章 | 董事和董事会 | 28 | | 第一节 | 董事的一般规定 28 | | | 第二节 | 董事会 | 32 | | 第三节 | 独立董事 36 | | | 第四节 | 董事会专门委员会 39 | | | 第六章 | 高级管理人员 | 41 | | 第七章 | 财务会计制度、利润分配和审计 4 ...